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Abstract
Late-infantile ceroid-lipofuscinosis is a fatal autosomal recessively inherited disease characterized by massive accumula-
tions of lysosomal storage bodies in many tissues. A major constituent of the storage bodies is the subunit c protein of
mitochondrial ATP synthase. Juvenile ceroid-lipofuscinosis, a disease that is similar to but genetically distinct from the
late-infantile disorder, also involves lysosomal accumulation of the subunit c protein. In the juvenile disease, the stored form
 .of the protein contains an e-N-trimethyllysine TML residue at position 43. Analyses were performed to determine whether
subunit c protein stored in the late-infantile disease is also trimethylated at lysine residue 43. Amino acid composition
analysis of the subunit c protein stored in brains from subjects with the late-infantile disease indicated that one of the two
lysine residues in the protein is trimethylated. Data from molecular mass analysis of the protein was consistent with the
presence of three methyl groups not present in the unmodified protein. The TML in the storage body subunit c protein was
found by amino acid sequence analysis to occur exclusively at residue 43. The lysine at this position in the stored protein
was completely methylated. Recent studies suggest that the subunit c protein from normal mitochondria may also have the
same amino acid modification. Thus, it appears that specific methylation of lysine residue 43 of mitochondrial ATP
synthase subunit c is probably a normal post-translational modification, and that the lysosomal storage of this protein in
late-infantile, as well as in juvenile ceroid-lipofuscinosis, does not result from a defect in its methylation.
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1. Introduction
The childhood-onset ceroid-lipofuscinoses are a
group of autosomal recessively inherited disorders
characterized by massive accumulation of autofluo-
rescent lysosomal storage bodies in neurons and many
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other cell types. Clinical symptoms in children with
these diseases include visual loss, seizures, psy-
chomotor and cognitive deterioration, and premature
w xdeath 1–3 . The childhood ceroid-lipofuscinoses have
been divided into three major forms based on both
clinical and, more recently, genetic criteria. These
forms are commonly referred to as the infantile,
late-infantile, and juvenile types reflecting differences
in the ages at which clinical symptoms first appear
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w x1–3 . Each of these forms of ceroid-lipofuscinosis is
w xgenetically distinct 4–12 . In the late-infantile and
juvenile forms, the lysosomal storage material con-
tains large amounts of the subunit c protein of mito-
w xchondrial ATP synthase 13,14 . The metabolic basis
for the accumulation of this protein is currently not
known.
Analysis of the subunit c protein from the lysoso-
mal storage bodies of subjects with the juvenile type
of ceroid-lipofuscinosis revealed that the stored form
of the protein contained the modified amino acid
 . w xe-N-trimethyl-L-lysine TML at position 43 15 . On
the basis of amino acid sequence analysis, it was
reported that the normal mitochondrial protein con-
tains two lysine residues, neither of which is trimeth-
w xylated 16,17 . Recently reported mass spectral data,
however, is consistent with trimethylation of the ly-
sine residue at position 43 in the normal mitochon-
w xdrial protein 18 . It therefore appears likely that the
methylation of this lysine residue is a normal post-
translational modification. It is possible that a defect
in methylation of subunit c could result in abnormal
processing of this protein and thus account for its
lysosomal accumulation in late-infantile ceroid-lipo-
fuscinosis. The subunit c in lysosomal storage bodies
from the late-infantile disease has not previously
been analyzed for the presence of TML. However,
analysis of a total storage body protein hydrolysate
from a single subject diagnosed with this disorder did
w xnot reveal the presence of any detectable TML 19 .
Rather, another methylated amino acid, S-methyl-
methionine, was associated with the stored protein.
With the acquisition of tissue samples from addi-
tional donors diagnosed with late-infantile ceroid-li-
pofuscinosis, analyses were performed to determine
whether either TML or S-methylmethionine was pre-
sent in the storage body subunit c in this form of the
disease.
2. Materials and methods
2.1. Storage body isolation
Cerebral cortex tissue was obtained post mortem
from five human donors who were diagnosed as
having the late-infantile form of ceroid-lipofuscino-
sis. The tissues were obtained as soon after death as
possible and stored frozen at y708C until used.
Tissue donors died between the ages of 7 and 11 yr.
Two of the samples were obtained from the National
Neurological Research Bank, VAMC Wadsworth, Los
Angeles, CA, USA and the remainder were obtained
directly from the donor families.
Isolation of the disease-specific lysosomal storage
bodies from the tissues was performed using a com-
bination of differential and buoyant density centrifu-
w xgation 20 . Approximately 6 g of primarily gray
matter was dissected from each frozen brain speci-
men. The sample was divided into four relatively
equal pieces and each piece was homogenized in 25
ml of ice-cold 0.4 mM Tris, pH 7.40. The ho-
mogenates were filtered through glass wool and then
subjected to sonication on ice for 1 min with a
Branson model 185 sonifier set for an output of 30
W. The samples were then centrifuged for 20 min at
2200=g . All centrifugation steps were carried outav
at 48C in a swinging-bucket rotor. The supernatants
from the first centrifugation step were decanted and
discarded and the pellets were each suspended in 4
ml of water and sonicated for 45 s as described
above. The suspensions were pooled and diluted to a
total volume of approximately 40 ml. The samples
were then centrifuged in two equal aliquots for 20
min at 2700=g . After removing the supernatants,av
each pellet was suspended in 5 ml of 1.395 M CsCl
 .in 0.4 mM Tris, pH 7.4 density 1.174 grml . The
suspensions were pooled and centrifuged at 10 800=
g for 50 min. The supernatant was discarded andav
the pellet was suspended in 12 ml of 1.60 M CsCl in
 .0.4 mM Tris, pH 7.4 density 1.203 grml . The
suspensions were again centrifuged at 10 800=gav
for 50 min. After removal of the supernatant, the
pellet was suspended in 4 ml of water and cen-
trifuged for 30 min at 2700=g . The resultingav
pellet was washed one more time with 3 ml of water.
This pellet consisted of purified storage bodies.
The purities of the storage body preparations were
assessed with electron microscopy. Suspensions of
the isolated storage bodies were added to a mixed
w xaldehyde fixative 21 at room temperature and were
pelleted by centrifugation at 6000=g for 3 min.av
The pellets were fixed for at least 2 h at room
temperature with gentle agitation. The samples were
then washed, fixed with OsO , dehydrated and em-4
w xbedded in plastic as described previously 21 . Ultra-
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thin sections of the embedded samples were cut,
stained with lead citrate and uranyl acetate, and were
examined with a JEOL 1200EX electron microscope.
2.2. Subunit c extraction from storage bodies
The subunit c protein was extracted from the
storage bodies using a modification of the technique
w xdescribed by Fearnley and colleagues 22 . To each
sample of isolated storage bodies obtained from ap-
proximately 6 g of tissue was added 6.0 ml of 2:1
 .vrv of chloroformrmethanol containing 100 mM
ammonium acetate. Each sample was then vortex
mixed for 30 s followed by sonication on ice for 30 s.
This was followed by the addition of one ml of water
to the sample. After vortex mixing for 30 s, the
extraction mixtures were allowed to stand on ice for
20 min. They were then centrifuged at 6000=g forav
10 min to separate the organic and aqueous phases.
The lower organic phase was collected and trans-
ferred to another container. The remainder of the
sample was extracted with an additional 2 ml of 2:1
chloroformrmethanol containing 100 mM ammo-
nium acetate, and the resulting organic phase was
collected and pooled with the first organic phase.
Vacuum evaporation was used to concentrate the
extract to a volume of approximately 200 ml. The
concentrate was then mixed with 4 ml of diethyl
ether that had been cooled to y208C. To precipitate
the protein, the sample was incubated at y708C for
at least 2 h. After centrifugation at 2100=g for 25av
min, the ether was removed from the protein pellet
which was then washed twice with methanol and
twice with water. The resulting sample was stored
under argon at y708C until is was used in subse-
quent analyses.
2.3. Gel electrophoresis
The subunit c preparations obtained from the stor-
age bodies were subjected to SDSrPAGE to assess
their protein compositions. SDSrPAGE was per-
formed as described previously for subunit c prepara-
tions from human donors with juvenile Batten disease
w xand animals with analogous diseases 23 . After fixa-
tion, the gels were stained with silver nitrate to allow
w xvisualization of the subunit c 23,24 .
2.4. Amino acid composition and sequence analyses
Aliquots of each isolated protein sample were
subjected to quantitative amino acid composition
analysis. Each sample was vacuum dried to a con-
stant weight and then suspended in 6 M HCl at a
concentration of 2 mg per ml. The samples were then
purged with argon and incubated at 110–1158C for
24 h. The amino acid compositions of the resulting
digests were determined with a Beckman model 6300
amino acid analyzer. Quantification was based on the
analysis of amino acid standards, including TML and
S-methylmethionine.
The storage body subunit c preparations were sub-
jected to N-terminal amino acid sequence analyses as
described previously for the protein isolated from
w xtissues of donors with the juvenile disease 15 . An
aliquot of each sample was solubilized by incubation
in 1% SDS at room temperature for 60 min at a
protein concentration of approximately 2 mgrml.
The resulting solution was subjected to centrifugation
at 10,000 g for 15 min, and 100 ml of the supernatant
 .was applied to a ProSorb poly vinylidene difluoride
 .  .PVDF Applied BioSystems membrane. The pro-
teins that bound to the membrane were then subjected
to amino acid sequence analysis with an Applied
BioSystems 470 gas-phase sequencer equipped with a
 .model 120 phenylthiohydantoin PTH analyzer. Se-
quence analysis was performed on the first 10 residues
from each sample. This was sufficient to identify the
amino acid residue at position 7 in the stored protein.
In mitochondrial subunit c, residue 7 is reported to be
the first of two lysine residues in the protein
w x16,17,25 .
Sequence analyses were also performed to deter-
mine the identity of the amino acid residue at posi-
tion 43 in the stored protein. This is the reported
location of the second lysine residue in mitochondrial
w xsubunit c 16,17,26 . The repetitive yields obtained
upon sequencing the intact protein were not sufficient
to allow sequencing from the amino terminal through
residue 43. In order to obtain sequence data from the
region of the protein containing the latter residue, the
storage body protein was bound to a ProSorb PVDF
membrane as described above. The bound protein
was then subjected to trypsin cleavage as described
w xpreviously 15 . After trypsin treatment, the mem-
branes were washed and the protein fragments re-
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maining bound were subjected to amino acid se-
quence analysis. Between the first and second cycles
of Edman degradation, the membranes were treated
 .with o-phthalaldehyde OPA to block any sequences
arising from the amino terminus or from fragments
generated by cleavage of the protein at any sites other
than the trypsin-cleavage site at the carboxyl side of
w xarginine residue 38 15,27 . Residue 40 of mitochon-
drial subunit c is proline, which is the only amino
acid that does not react with OPA. Excess OPA was
then washed from the membranes, and sequence anal-
ysis was continued for at least seven additional
residues.
2.5. Mass spectral analysis
For molecular mass determinations aliquots of the
subunit c preparations from three of the donors were
subjected to mass spectral analysis using two differ-
ent techniques. Chloroform-methanol extracts of the
storage bodies were partially concentrated by vacuum
evaporation of the solvent. The samples were then
analyzed with matrix assisted laser desorption ioniza-
 .tion MALDI mass spectrometry at the University of
Michigan Protein and Carbohydrate Structure Facility
w x28 . Additional aliquots of the subunit c protein
isolated from the storage bodies were analysed using
 .electrospray ionization mass spectrometry ESI-MS .
Subunit c samples, isolated as described above, were
dried under vacuum and then dissolved in 88% formic
acid. The resulting solutions were diluted with 20
 .volumes of 2:1 chloroform:methanol vrv to obtain
a final concentration of subunit c of approximately 50
nmol per ml. Molecular mass analysis was performed
 .with a Finnigan model SSQ 710C San Jose, CA
mass spectrometer equipped with an electrospray ion-
ization source. The instrument was tuned and cali-
 .brated using a MRFA peptide 20 pmolrml and
 .apomyoglobin protein 5 pmolrml mixture dissolved
 .in methanol:water:acetic acid 47.5:47.5:5 using the
auto tune program with typical unit mass resolution.
A capillary temperature of 2008C and a dry nitrogen
sheath gas flow at 40 psi were maintained during the
electrospray process. The high voltage for the ESI
source was 4 kV. The protein solution was directly
infused into the mass spectrometer at an infusion rate
of 4 mlrmin. The mass spectrum was obtained by
averaging data collected over a 5 min. period, with
the scanning performed over the 1000 to 2000 mrz
range. The raw mass spectrum contained peaks corre-
 .4q  .5q sponding to the Mq4H , Mq5H , Mq
.6q  .7q6H , and Mq7H species.
3. Results
Differential and buoyant-density centrifugation of
brain tissue homogenates from donors with late-in-
fantile ceroid-lipofuscinosis yielded preparations that
consisted of almost pure storage bodies, as indicated
 .by electron microscopic examination Fig. 1 . The
ultrastructural appearance of these storage bodies is
quite distinctive and differs from that of storage
bodies from brain tissues of subjects with the classi-
w xcal juvenile and infantile forms of the disease 29 .
Chloroformrmethanol extraction of the storage bod-
ies and ether precipitation from the extracts yielded
almost pure subunit c protein, as assessed by
 .SDSrPAGE Fig. 2 . Quantitative amino acid com-
position analyses were performed on HCl digests of
these subunit c preparations. In all cases the amino
acid compositions were quite close to those predicted
Fig. 1. Electron micrograph illustrating the ultrastructural appear-
ance of storage bodies isolated from the brains of subjects with
late-infantile ceroid-lipofuscinosis.
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from the reported amino acid sequence of bovine
mitochondrial subunit c, with the notable exception
that the lysine contents were about half that of the
mitochondrial protein, and TML and lysine were
present in approximately equimolar amounts Table
.1 . The identity of the TML detected in the chromato-
grams of the protein hydrolysates was confirmed by
co-chromatography with synthetic TML standards on
both thin layer and ion-exchange chromatography,
and by fast atom bombardment mass spectral analysis
w x30 . No S-methylmethionine was detected in the
hydrolysates. This suggested that, as in the juvenile
form of the disease, one of the two lysine residues in
the storage body form of subunit c is trimethylated.
The presence of three excess methyl groups in the
stored form of subunit c was confirmed by both
MALDI-MS and electrospray ionization-MS. The un-
modified protein has a theoretical molecular mass of
7608. The addition of three methyl groups to one of
the lysine residues would be expected to increase the
mass by 42 mass units. MALDI-MS analysis indi-
cated an average molecular mass of 7647 for the
subunit c isolated from the storage bodies. This is
Fig. 2. SDSrPAGE analysis of storage body proteins isolated
from brains of subjects with late-infantile ceroid-lipofuscinosis.
Lysosomal storage bodies were isolated from brain tissues of
donors with late-infantile ceroid-lipofuscinosis as described in the
Materials and methods section. Aliquots of the isolated storage
bodies were subjected to chloroformrmethanol extraction, and
subunit c was precipitated from these extracts with ether. The
isolated proteins were solubilized with SDS and analyzed with
wSDSrPAGE. Lane 1, molecular mass standards approximately
100 ng each of CNBr-cleavage products of horse heart myo-
 . xglobin with molecular masses in kDa given on the left ; lanes 2
through 6, proteins isolated from the brain storage bodies of the
human donors diagnosed with late-infantile ceroid-lipofuscinosis.
Approximately 150 ng of total storage body protein was applied
to each of lanes 2 through 6. The band indicated with an arrow
w xhas the same mobility as the mitochondrial subunit c protein 22 .
Table 1
Comparison of amino acid composition of subunit c from storage
bodies of subjects with late-infantile ceroid-lipofuscinosis to the
predicted composition based on the reported amino acid sequence
of the protein from normal mitochondria
Amino acid Composition
a .molr100 mol total amino acids
Storage body subunit c Theoretical
Asx 4.1 4.0
Thr 4.1 4.0
Ser 6.0 6.7
Glx 4.3 4.0
Pro 1.9 1.3
Gly 14.4 14.7
Ala 16.7 17.3
Cys 1.0 1.3
Val 5.8 5.3
Met 3.7 4.0
Ile 9.0 9.3
Leu 12.4 12.0
Tyr 3.0 2.7
Phe 9.2 9.3
His 0.2 0.0
Lys 1.4 2.7
Arg 1.6 1.3
TML 1.3 0.0
a The values for the storage body subunit c composition are the
means of values obtained from analysis of samples from five
different donors.
within 0.04% of the theoretical mass of 7650 pre-
dicted for the subunit c protein in which one lysine
residue is trimethylated. Mass determinations using
MALDI-MS are typically accurate to within 0.01 to
w x0.1% 28 . Thus, the MALDI-MS data are consistent
with trimethylation of one of the lysine residues in
the stored protein. Further support for the presence of
this modification to the protein was provided by
electrospray ionization mass spectral analysis Fig.
.3 . This analysis indicated that the dominant species
had masses of 7650 and 7666 Da. No species with a
mass of 7608, coressponding to nonmethylated sub-
 .unit c, was detected Fig. 3 . The species with a mass
of 7650 is consistent with trimethylation of the pro-
tein. The species with a mass of 7666 may represent
the addition of oxygen to the trimethylated protein,
perhaps due to the oxidation of a methionine residue
w x31 . The mass spectrum also contained species that
were approximately 23 mass units greater than the
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Fig. 3. Electrospray ionization mass spectrum of subunit c protein preparation isolated from brain storage bodies from a donor with
w x4q w x5qlate-infantile ceroid-lipofuscinosis. The groupings of peaks labeled 4q , 5q , 6q , and 7q correspond to the Mq4H , Mq5H ,
w x6q w x7qMq6H , and Mq7H species respectively. The inset shows an expanded view of the 4q region of the spectrum. The species
with mrz 1913.5 corresponds to component of molecular mass 7650"3 Da. This is the predicted mass of the subunit c protein that is
w xtrimethylated at lysine residue 43. The species with mrz 1917.3 may be an oxidized form of trimethylated subunit c 31 . The species
with mrz 1919.4 and 1922.6 are likely to be the nonoxidized and oxidized forms of trimethylaed subunit c with one mole of sodium
bound per mole of protein. The components with lower mrz probably represent smaller contaminating proteins or peptides. The mrz
w x4qpredicted for the Mq4H species derived from the nonmethylated form of subunit c is 1903. Note that no component with this mrz
 .was detected in the mass spectrum arrow in inset .
 .7650 and 7666 species Fig. 3 . This is consistent
with the binding of sodium to a fraction of the
protein molecules. In addition to the cluster of species
related to the subunit c protein, there was also a
cluster of minor species of lower mass that may
represent other small hydrophobic proteins also ex-
tracted from the storage bodies or truncated forms of
 .subunit c Fig. 3 .
Fig. 4. Amino acid sequence analysis of chloroform-methanol extracted storage body proteins from subjects with late-infantile
ceroid-lipofuscinosis. The amino acid sequence shown is that predicted for human mitochondrial ATP synthase subunit c based on cDNA
w x w xsequence analysis 25,26 . Residue 43, indicated by X, was reported to be lysine in the normal bovine mitochondrial protein 16,17 . The
vertical arrows above the sequence indicate the trypsin cleavage sites. The dashed lines below the sequence indicate portions of the
sequence determined for the protein isolated from the brain storage bodies. In the sequences obtained from these samples X was identified
as TML by the chromatographic retention of its PTH derivative on the amino acid sequencer.
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Mitochondrial subunit c has two lysine residues,
one at residue 7 and the other at residue 43. Partial
amino acid sequence analyses indicated that in the
juvenile form of the disease, the lysine residue at
w xposition 43 is trimethylated 15 . To determine which
of the two lysine residues is trimethylated in the
protein stored in the late-infantile disease, the isolated
protein was subjected to N-terminal amino acid se-
quence analysis through 10 cycles of Edman degrada-
tion. In all cases the observed sequence was DID-
 .TAAKFIG Fig. 4 . Cycle 7 yielded only lysine, with
no evidence of TML. This finding indicated that the
TML residue identified by amino acid composition
analysis must be at position 43. To confirm this,
internal sequence analysis of residues 39 through 48
was performed on the stored protein. This analysis
 .confirmed that amino acid 43 was TML Fig. 4 . No
unmodified lysine was detected at this position in the
protein.
4. Discussion
The subunit c protein of mitochondrial ATP syn-
thase has been shown to be a major constituent of the
lysosomal storage material that accumulates in the
tissues of children with late-infantile as well as juve-
w xnile ceroid-lipofuscinosis 13,32 . The metabolic bases
for the specific lysosomal storage of this one particu-
lar protein are presently unknown for either form of
the disease. The juvenile and late-infantile diseases
are genetically distinct disorders. The gene that is
defective in the juvenile disease maps to human
w xchromosome 16p12 8–10,33 , whereas linkage anal-
ysis has excluded chromosome 16 localization for the
w xgene defect in the late-infantile disease 34 . There-
fore, the precise genetic and biochemical defects
responsible for subunit c protein storage must be
different for these two diseases.
Nucleotide sequence analysis of subunit c cDNA
from several species, including humans, indicates that
the amino acid expected at position 43 is lysine
w x22,26,35 . Complete amino acid sequence analysis
has been performed on the subunit c protein from
storage bodies of sheep with a disease thought to be
analogous to human juvenile ceroid-lipofuscinosis
w x22 . This analysis failed to detect lysine at position
43, but the identity of the amino acid at this position
was not determined. The remainder of the amino acid
sequence was identical to that predicted for the hu-
w xman protein based on the cDNA sequence 22,26 .
Previous analyses of the storage body subunit c pro-
tein from subjects with the juvenile disease revealed
that the e-amino group of the lysine residue at posi-
w xtion 43 was trimethylated 15 . The only reported
complete amino acid sequence analysis of the subunit
c from normal mitochondria indicated that this lysine
w xresidue is not ordinarily methylated 16,17 . How-
ever, recent mass spectral analysis of the protein from
beef heart mitochondria is consistent with trimethyla-
w xtion of the lysine at position 43 18 , suggesting that
in the sequencing study TML may not have been
resolved from unmodified lysine. On the basis of the
recent mass spectral data, it appears likely that meth-
ylation of subunit c residue 43 is a normal post-trans-
lation modification. Since the protein that accumu-
lates in juvenile ceroid-lipofuscinosis contains this
modification, the lysosomal storage of the protein
does not appear to involve a defect in methylation
that could affect subsequent processing of the protein.
Because the juvenile and late-infantile forms of
ceroid-lipofuscinosis are clearly genetically distinct
entities, the molecular basis for lysosomal subunit c
storage must be different for the two diseases. Thus,
although a defect in subunit c methylation does not
appear to be involved in the juvenile disease, it
appeared quite possible that such a defect was re-
sponsible for the lysosomal accumulation of subunit c
in the late-infantile disease. In 1990, a total storage
body protein HCl digest from a subject purported to
have the late-infantile disease was analyzed for the
w xpresence of modified amino acids 19 . No TML was
detected, but rather, the hydrolysate was found to
contain the unusual amino acid S-methylmethionine.
Subsequently the subunit c protein was demonstrated
to be a major constituent of the storage bodies in the
w xlate-infantile disease 13,32 . It was therefore hypoth-
esized that one of the methionine residues was meth-
ylated in subunit c stored in the latter form of ceroid-
lipofuscinosis, rather than the lysine residue at posi-
tion 43 that is normally trimethylated. To test this
hypothesis, subunit c isolated from the storage bodies
of five human donors with the late-infantile disease
was analyzed.
Contrary to the previous finding, TML was found
to be present in the subunit c preparations from every
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affected donor, whereas S-methylmethionine was not
detected. This suggests that the donor from which the
previous sample was obtained had a disease that
differed from classical late-infantile ceroid-lipo-
fuscinosis. Tissue from that donor was no longer
available for further analysis. The gene defect respon-
sible for the late-infantile disease has not yet been
w xdetermined 34 . Therefore, diagnosis is usually based
exclusively on clinical symptoms and microscopic
examination of tissue biopsies for the presence of
lysosomal storage bodies. It is clear that several
similar disorders often cannot be distinguished on the
w xbasis of these criteria alone 1,36 . Indeed, recent
genetic linkage studies suggest that not all cases
classified as late-infantile ceroid-lipofuscinosis have
w xthe same gene defect 34 . Thus it is likely that the
failure to detect TML in the total protein hydrolysate
of the storage bodies from the donor reported on in a
previous study was due to the fact that this subject
did not have the classical late-infantile disease. It is
possible that the latter individual had one of the
reported variant forms of the disease, and that in this
sub-type the genetic defect did result in an alteration
in subunit c methylation.
It is not presently known what role trimethylation
of lysine residue 43 of mitochondrial ATP synthase
subunit c plays in the normal function or processing
of this protein. It was previously proposed that the
protein is normally methylated in the mitochondria
w x15 , and recent mass spectral data support this hy-
w xpothesis 18 . The methylation may be required to
initiate degradation of the protein. The free TML
released upon degradation of the methylated protein
is a precursor in the biosynthesis of carnitine, a
compound that plays an important role in mitochon-
w xdrial fatty acid uptake and metabolism 37 . A defect
in the carnitine biosynthetic pathway would impair
metabolism of TML to carnitine. The resulting build-
up of TML in cells could inhibit degradation of
TML-containing subunit c, possibly through competi-
tive binding to a TML-recognition site of a protease
that specifically recognizes the methylated form of
w xsubunit c 15 . If TML-containing subunit c is a
significant contributor to carnitine biosynthesis, and
if carnitine biosynthesis is impaired in ceroid-lipo-
fuscinosis, one would predict that carnitine levels
would be lower than normal in affected individuals.
This was indeed found to be the case in subjects with
w xthe juvenile form of the disease 38 . Preliminary data
indicates that carnitine levels are also significantly
depressed in children with late-infantile ceroid-lipo-
fuscinosis. Among seven children diagnosed with the
late-infantile disease, total plasma carnitine was found
 .to be 37.3"6.0 nmolrml mean"SD , as opposed
to normal individuals in whom total plasma carnitine
w xconcentrations are 51.9"12.0 nmolrml 38 . In the
juvenile disease, it appears that the depressed carni-
tine levels result not from a failure to convert free
TML to carnitine, but rather from an impaired ability
to produce free TML, presumably from the break-
w xdown of TML-containing subunit c 38 . In the juve-
nile disease, therefore, it appears likely that the accu-
mulation of subunit c results from a defect in initia-
tion of degradation of the protein that does not
involve accumulation of free TML. Free TML levels
have not yet been measured in subjects with the
late-infantile disease. Thus, it remains possible that in
the latter form of ceroid-lipofuscinosis, there is a
defect in the carnitine biosynthetic pathway.
In late-infantile ceroid-lipofuscinosis impaired sub-
unit c turnover is expressed in the mitochondria.
Pulse-chase labeling experiments indicated that in
cells cultured from affected subjects, this protein is
synthesized and appears in the mitochondria at a
normal rate, but disappears from this organelle at a
w xmuch slower than normal rate 39 . This finding is
consistent with the hypothesis that subunit c methyla-
tion occurs normally in the mitochondria and is re-
quired for normal degradation of the protein. A defect
in recognition of the methylation could account for
the accumulation of subunit c within the mitochon-
dria. The lysosomal localization of stored subunit c in
both juvenile and late-infantile ceroid-lipofuscinoses
is likely to be secondary to the accumulation of the
protein in mitochondria. It appears that only after
failure in the degradation of the protein by its normal
w xpathway does the protein appear in lysosomes 39,40 .
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